Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

A Look At Leqvio’s Lacklustre Launch

Novartis Cholesterol Drug Sales Still Stuck

Jul 26 2023

• By Kevin Grogan

Novartis — • Source: Novartis

Related Content

It's Time For Novartis To Put Its Leqvio Launch Strategy To The Test

Dec 22 2021

All Systems Go For Novartis 'World-First' Leqvio Pact With England

Sep 01 2021

Novartis Leqvio Launch Lags As COVID-19 Hinders England Access Scheme

Feb 02 2022

Eyebrows Raised As Roche Inks Cardiovascular Pact With Alnylam

Jul 24 2023

Novartis Bets On Buybacks Due To Limited M&A Options

Jul 18 2023

Novartis Gets Expansion For Earlier Use Of Leqvio

Jul 11 2023

Related Companies

Novartis AG

Sanofi

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc.

Additional Topics

Launches Clinical Trials Commercial Business Strategies Cardiovascular BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.